Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrik Tarp

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Annals of the Rheumatic Diseases|October 6, 2011
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaborationKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
Annals of the Rheumatic Diseases|May 17, 2011
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registriesKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
Annals of the Rheumatic Diseases|September 4, 2012
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registryBente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Annals of the Rheumatic Diseases|February 4, 2012
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRPMerete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, et al.
Arthritis and Rheumatism|April 29, 2006
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled studyMerete Lund Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Arthritis Research & Therapy|February 18, 2016
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaborationKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.
Annals of the Rheumatic Diseases|July 27, 2014
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryPil Højgaard, Bente Glintborg, Merete Lund Hetland, et al.
Arthritis Research & Therapy|June 22, 2016
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaborationKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
The Journal of Rheumatology|May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritisAnne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Annals of the Rheumatic Diseases|October 6, 2011
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaborationKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
Annals of the Rheumatic Diseases|May 17, 2011
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registriesKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
Annals of the Rheumatic Diseases|September 4, 2012
Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor α inhibitor therapy: results from the Danish nationwide DANBIO registryBente Glintborg, Mikkel Østergaard, Niels Steen Krogh, et al.
Annals of the Rheumatic Diseases|February 4, 2012
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRPMerete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, et al.
Arthritis and Rheumatism|April 29, 2006
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled studyMerete Lund Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Arthritis Research & Therapy|February 18, 2016
Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaborationKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
Annals of the Rheumatic Diseases|September 5, 2012
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO RegistryLene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, et al.
Annals of the Rheumatic Diseases|July 27, 2014
Association between tobacco smoking and response to tumour necrosis factor α inhibitor treatment in psoriatic arthritis: results from the DANBIO registryPil Højgaard, Bente Glintborg, Merete Lund Hetland, et al.
Arthritis Research & Therapy|June 22, 2016
Erratum to: Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaborationKaterina Chatzidionysiou, Elisabeth Lie, Evgeny Nasonov, et al.
The Journal of Rheumatology|May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritisAnne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.
Pageof 4